Mathue Baker in Clarinda, Iowa

Home Iowa Clarinda

Mathue Baker has Cardiovascular Disease (cardiology) as his primary medical specialty. Their primary office is: 220 Essie Davison Dr in Clarinda, Iowa. There are 13 additional office locations for Mathue Baker that can be viewed towards the end of their profile.

They're a part of the: Integrated Cardiology Group Llc medical group which has around 73 members. You can call their office at 712-542-2176 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended University Of Nebraska College Of Medicine and graduated in 2005 (around 19 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.

Mathue M Baker Office Phone and Directions

Mathue Baker
Integrated Cardiology Group Llc
220 Essie Davison Dr
Clarinda, Iowa 51632
712-542-2176

Patient Ratings
Please rate your experience with Mathue Baker below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 712-542-2176

Enter a starting address:

Healthcare Info for Mathue Baker

Additional Medical Specialties Include:
INTERNAL MEDICINE, CARDIOVASCULAR DISEASE (CARDIOLOGY)

Medical School: University Of Nebraska College Of Medicine
Graduation Year: 2005
The Primary Medical Specialty for Mathue Baker is listed as: Cardiovascular Disease (cardiology)
Approximate Years of Experience: 19
PAC (PECOS ID)#: 3375604580
NPI #: 1093936429
NPI Created On: 05/02/2007
NPI Last Updated Listed as: 04/10/2020
Primary Taxonomy Code: 207R00000X
License Number:
23935
Listed Gender: Male

Insurance, Services, Charges

Forms of insurance accepted by include, but are not limited to:

Medica Insurance Company
Humana
Blue Cross Blue Shield
Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English, French, Arabic.

Services and Procedures include:

Multiple nuclear medicine studies of blood flow in heart muscle at rest and with stress, with concurrently acquired ct transmission scan
Nuclear medicine study of vessels of heart using drugs or exercise multiple studies
Natriuretic peptide (heart and blood vessel protein) level
External shock to heart to regulate heart beat
Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report
Exercise or drug-induced heart and blood vessel stress test with ekg monitoring and physician supervision
Exercise or drug-induced heart and blood vessel stress test with ekg monitoring, physician interpretation and report
Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function
Follow-up or limited ultrasound examination of heart
Insertion of probe in esophagus for heart ultrasound examination including interpretation and report
Doppler ultrasound study of heart blood flow, valves, and chambers
Follow-up or limited heart doppler ultrasound study of heart blood flow, valves, and chambers
Doppler ultrasound study of color-directed heart blood flow, rate, and valve function
Insertion of catheter in left heart for imaging of blood vessels or grafts and left lower heart
Moderate sedation services by physician also performing a procedure, patient 5 years of age or older, first 15 minutes
New patient office or other outpatient visit, typically 20 minutes
New patient office or other outpatient visit, typically 20 minutes
New patient office or other outpatient visit, typically 30 minutes
New patient office or other outpatient visit, typically 30 minutes
New patient office or other outpatient visit, typically 45 minutes

They took part in Medicare's Electronic Health Record Incentive Program which was designed to help move people over to electronic records and improve the systems that were already in place.
They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $15

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 787747217

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiovascular & Metabolism

Name of Drug #1: XARELTO

Open Associated Drug #1: 50458-580-30

Payments Total: $20

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 787747235

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiovascular & Metabolism

Name of Drug #1: XARELTO

Open Associated Drug #1: 50458-580-30

Payments Total: $18

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 783660883

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiovascular

Name of Drug #1: ELIQUIS

Open Associated Drug #1: 0003-0894-31

Payments Total: $11

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 768818096

Being Disputed:: No

Product Related: Yes

Drug or Biological: Device

Product Category #1: Electromedical and Electrotherapeutic Apparatus

Name of Drug #1: LifeVest

Payments Total: $33

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 768818094

Being Disputed:: No

Product Related: Yes

Drug or Biological: Device

Product Category #1: Electromedical and Electrotherapeutic Apparatus

Name of Drug #1: LifeVest

Payments Total: $4

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 768818098

Being Disputed:: No

Product Related: Yes

Drug or Biological: Device

Product Category #1: Electromedical and Electrotherapeutic Apparatus

Name of Drug #1: LifeVest

Payments Total: $17

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 843628329

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiology/Vascular Diseases

Name of Drug #1: MULTAQ

Open Associated Drug #1: 0024-4142-10

Payments Total: $19

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 832593795

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: CARDIOVASCULAR;METABOLIC DISEASE

Name of Drug #1: ELIQUIS

Open Associated Drug #1: 0003-0893-21

Drug or Biological: Drug

Product Category #2: CARDIOVASCULAR

Name Of Drug #2:: VYNDAQEL

Associated Drug #2: 0069-8729-55

Payments Total: $19

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 832599369

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: CARDIOVASCULAR;METABOLIC DISEASE

Name of Drug #1: ELIQUIS

Open Associated Drug #1: 0003-0893-21

Drug or Biological: Drug

Product Category #2: CARDIOVASCULAR

Name Of Drug #2:: VYNDAQEL

Associated Drug #2: 0069-8729-55

Payments Total: $17

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 832726033

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: CARDIOVASCULAR;METABOLIC DISEASE

Name of Drug #1: ELIQUIS

Open Associated Drug #1: 0003-0893-21

Drug or Biological: Drug

Product Category #2: CARDIOVASCULAR

Name Of Drug #2:: VYNDAQEL

Associated Drug #2: 0069-8729-55

Additional Office Locations

1. The Mary Lanning Memorial Hospital Association
715 N Saint Joseph Ave
Hastings, NE 68901
Mary Lanning Healthcare
Group Members: 123